Christopher J. Rezendes filed an initial statement of beneficial ownership with the SEC on November 2, 2026, disclosing his status as a newly reportable director of Narragansett Bancorp, Inc. (NASDAQ:NARA).

Key Highlights

  • Reporting person: Christopher J. Rezendes, identified in the filing as a Director of Narragansett Bancorp, Inc.
  • Event date: The date of event requiring the statement is listed as November 2, 2026.
  • Direct holdings: Rezendes reported direct beneficial ownership of 500 shares of Narragansett Bancorp Common Stock.
  • No derivative securities: Table II of the filing lists no derivative securities beneficially owned.
  • Filing agent: The form was signed by Marie Pellegrino pursuant to a power of attorney, on November 2, 2026.

Rezendes Reports Initial Director Holdings at Narragansett Bancorp

Christopher J. Rezendes, whose address is listed as 330 Swansea Mall Drive, Swansea, Massachusetts 02777, submitted a Form 3 to the SEC identifying himself as a Director of Narragansett Bancorp, Inc., traded on NASDAQ:NARA. The filing covers his initial beneficial ownership as of November 2, 2026, the date of the event requiring the statement, according to the disclosure.

According to the filing, Rezendes directly owns 500 shares of Narragansett Bancorp Common Stock. The ownership form is designated as direct ("D") in Table I. No indirect holdings and no derivative securities, such as puts, calls, warrants, options, or convertible securities, were reported in Table II of the form.

The form was filed by one reporting person and was signed by Marie Pellegrino, acting pursuant to a power of attorney, also dated November 2, 2026. The filing was submitted under Section 16(a) of the Securities Exchange Act of 1934, which requires officers, directors, and certain shareholders to disclose their initial beneficial ownership of issuer securities.

What Was Disclosed

Christopher J. Rezendes disclosed an initial beneficial ownership of 500 shares of Narragansett Bancorp Common Stock, held directly, in a Form 3 filed on November 2, 2026, in connection with his role as a Director of the company.